PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33170091-7	2022	Intriguingly, rosiglitazone (RGZ) and hydroxychloroquine (HCQ) were found to be mild-to-moderate inhibitors of hAChE (human acetylcholinesterase) in our enzyme inhibition studies which are complementary to our computational studies.	Hydroxychloroquine	38-56	acetylcholinesterase (Cartwright blood group)	Homo sapiens	111-116	
35411132-11	2022	Results: Molecular docking analysis revealed four putative key targets (ACHE, PNMT, MC1R, and VDR) of HCQ played important roles in vitiligo treatment.	Hydroxychloroquine	102-105	acetylcholinesterase (Cartwright blood group)	Homo sapiens	72-76	
35411132-16	2022	The protective effects of HCQ are mediated by binding to putative targets ACHE, PNMT, MC1R, and VDR according to network pharmacology and docking verification.	Hydroxychloroquine	26-29	acetylcholinesterase (Cartwright blood group)	Homo sapiens	74-78	
33170091-7	2022	Intriguingly, rosiglitazone (RGZ) and hydroxychloroquine (HCQ) were found to be mild-to-moderate inhibitors of hAChE (human acetylcholinesterase) in our enzyme inhibition studies which are complementary to our computational studies.	Hydroxychloroquine	38-56	acetylcholinesterase (Cartwright blood group)	Homo sapiens	124-144	
33170091-7	2022	Intriguingly, rosiglitazone (RGZ) and hydroxychloroquine (HCQ) were found to be mild-to-moderate inhibitors of hAChE (human acetylcholinesterase) in our enzyme inhibition studies which are complementary to our computational studies.	Hydroxychloroquine	58-61	acetylcholinesterase (Cartwright blood group)	Homo sapiens	111-116	
33170091-7	2022	Intriguingly, rosiglitazone (RGZ) and hydroxychloroquine (HCQ) were found to be mild-to-moderate inhibitors of hAChE (human acetylcholinesterase) in our enzyme inhibition studies which are complementary to our computational studies.	Hydroxychloroquine	58-61	acetylcholinesterase (Cartwright blood group)	Homo sapiens	124-144	
33170091-8	2022	On the basis of our computational and experimental studies, it can be suggested that the beneficial effect of RGZ and HCQ in AD patients reported in the literature may partly be due to their AChE inhibitory property.	Hydroxychloroquine	118-121	acetylcholinesterase (Cartwright blood group)	Homo sapiens	191-195